MX2010007784A - 2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran -4-il)-propionamida cristalina. - Google Patents

2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran -4-il)-propionamida cristalina.

Info

Publication number
MX2010007784A
MX2010007784A MX2010007784A MX2010007784A MX2010007784A MX 2010007784 A MX2010007784 A MX 2010007784A MX 2010007784 A MX2010007784 A MX 2010007784A MX 2010007784 A MX2010007784 A MX 2010007784A MX 2010007784 A MX2010007784 A MX 2010007784A
Authority
MX
Mexico
Prior art keywords
pyrazin
propionamide
crystalline
phenyl
cyclopropanesulphonyl
Prior art date
Application number
MX2010007784A
Other languages
English (en)
Inventor
Gregory Alan Stephenson
Jeanette Tower Dunlap
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40451065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010007784(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2010007784A publication Critical patent/MX2010007784A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen R-2-(4-ciclopropansulfonil-fenil)-N-pirazin-2-il-3-(t etrahidropiran-4-il)-propionamida cristalina y métodos para su preparación y uso. (ver fórmula).
MX2010007784A 2008-01-15 2009-01-07 2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran -4-il)-propionamida cristalina. MX2010007784A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2113308P 2008-01-15 2008-01-15
PCT/US2009/030241 WO2009091634A1 (en) 2008-01-15 2009-01-07 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide

Publications (1)

Publication Number Publication Date
MX2010007784A true MX2010007784A (es) 2010-08-09

Family

ID=40451065

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007784A MX2010007784A (es) 2008-01-15 2009-01-07 2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran -4-il)-propionamida cristalina.

Country Status (22)

Country Link
US (1) US20090181981A1 (es)
EP (1) EP2265271A1 (es)
JP (1) JP2011509934A (es)
KR (1) KR20100092061A (es)
CN (1) CN101909629A (es)
AR (1) AR070107A1 (es)
AU (1) AU2009205606A1 (es)
BR (1) BRPI0907165A2 (es)
CA (1) CA2712245A1 (es)
CL (1) CL2009000004A1 (es)
CO (1) CO6280489A2 (es)
DO (1) DOP2010000216A (es)
EA (1) EA201070853A1 (es)
EC (1) ECSP10010347A (es)
IL (1) IL206102A0 (es)
MA (1) MA31985B1 (es)
MX (1) MX2010007784A (es)
PE (1) PE20091313A1 (es)
TN (1) TN2010000299A1 (es)
TW (1) TW200934772A (es)
WO (1) WO2009091634A1 (es)
ZA (1) ZA201003909B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA08290520B1 (ar) 2007-08-22 2012-02-22 استرازينيكا ايه بي مشتقات سيكلو بروبيل أميد وتركيبات صيدلية تحتوي عليها لعلاج حالة مرضية سببها مستقبلات هيستامين h3
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
SG183274A1 (en) * 2010-02-18 2012-09-27 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
WO2011102793A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
KR101220371B1 (ko) 2010-09-17 2013-01-09 현대자동차주식회사 베인펌프
EP2674517B1 (en) * 2011-02-08 2018-10-03 Japan Agency for Marine-Earth Science and Technology Method for producing calcite single crystal
JP2013014534A (ja) * 2011-07-04 2013-01-24 Daicel Corp ベンゾイルギ酸化合物、及びその製造方法
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046768A (en) * 1976-06-17 1977-09-06 Velsicol Chemical Corporation 1-Thiazolyl-5-pyridylcarbonyloxyimidazolidinones
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6353111B1 (en) * 1999-12-15 2002-03-05 Hoffmann-La Roche Inc. Trans olefinic glucokinase activators
JP3788935B2 (ja) * 2000-05-03 2006-06-21 エフ．ホフマン−ラ ロシュ アーゲー アルキニルフェニルヘテロ芳香族グルコキナーゼ活性化物質
US6489485B2 (en) * 2000-05-08 2002-12-03 Hoffmann-La Roche Inc. Para-amine substituted phenylamide glucokinase activators
DE60106599T2 (de) * 2000-05-08 2006-02-09 F. Hoffmann-La Roche Ag Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
ES2243547T3 (es) * 2000-07-20 2005-12-01 F. Hoffmann-La Roche Ag Bencenacetamida sustituida para alfa-acilo y alfa heteroatomos como activador de glucokinasa.
US6369232B1 (en) * 2000-08-15 2002-04-09 Hoffmann-La Roche Inc. Tetrazolyl-phenyl acetamide glucokinase activators
US6433188B1 (en) * 2000-12-06 2002-08-13 Wendy Lea Corbett Fused heteroaromatic glucokinase activators
AU2002221902B2 (en) * 2000-12-06 2006-11-23 F. Hoffmann-La Roche Ag Fused heteroaromatic glucokinase activators
US6482951B2 (en) * 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
US6911545B2 (en) * 2001-12-19 2005-06-28 Hoffman-La Roche Inc. Crystals of glucokinase and methods of growing them
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
EP1594863A1 (en) * 2003-02-11 2005-11-16 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
EA012204B1 (ru) * 2004-04-21 2009-08-28 Прозидион Лимитед Три(цикло)замещённые амидные соединения
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process
GB0418046D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Eantioselective process
MX2007001650A (es) * 2004-08-12 2007-07-13 Prosidion Ltd Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
JP2009514836A (ja) * 2005-11-03 2009-04-09 プロシディオン・リミテッド トリシクロ置換型アミド
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
EP1948644A1 (en) * 2005-11-03 2008-07-30 Prosidion Limited Tricyclo substituted amides

Also Published As

Publication number Publication date
EP2265271A1 (en) 2010-12-29
CN101909629A (zh) 2010-12-08
MA31985B1 (fr) 2011-01-03
CL2009000004A1 (es) 2010-02-19
AR070107A1 (es) 2010-03-17
ZA201003909B (en) 2011-11-30
BRPI0907165A2 (pt) 2015-07-14
US20090181981A1 (en) 2009-07-16
WO2009091634A1 (en) 2009-07-23
TW200934772A (en) 2009-08-16
CO6280489A2 (es) 2011-05-20
KR20100092061A (ko) 2010-08-19
IL206102A0 (en) 2010-11-30
AU2009205606A1 (en) 2009-07-23
DOP2010000216A (es) 2010-10-15
CA2712245A1 (en) 2009-07-23
JP2011509934A (ja) 2011-03-31
ECSP10010347A (es) 2010-09-30
PE20091313A1 (es) 2009-09-03
TN2010000299A1 (en) 2011-11-11
EA201070853A1 (ru) 2010-12-30

Similar Documents

Publication Publication Date Title
MX2010007784A (es) 2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran -4-il)-propionamida cristalina.
AU2009276339A8 (en) Pyrimidine compounds, compositions and methods of use
SMT201600309B (it) Composizioni di dominio di fibronectina stabilizzate, metodi e usi
TN2011000673A1 (en) Bace inhibitors
MX353257B (es) Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1).
IL211541A0 (en) Co-crystal compositions, methods of producing the same and uses thereof
MY181898A (en) Heterocyclic compounds and uses thereof
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
WO2011032169A3 (en) Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
EP2269158A4 (en) NFC APPLICATION STARTER USING GBA
WO2010120994A3 (en) Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
EP2566477A4 (en) AMINO-QUINOLINES AS KINASE INHIBITORS
MX2012004780A (es) Inhibidores de akt.
AP2010005390A0 (en) Crystal form of phenylamino pyrimidine derivatives.
MX2013000446A (es) Formas solidas de romdepsina y sus usos.
MX2013002784A (es) Heteroarilos fusionados y sus usos.
HRP20171742T1 (hr) 2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
IN2012DN03404A (es)
EP2299814A4 (en) COMPOSITIONS, SYNTHESIS AND METHOD FOR USE OF ANTIPSYCHOTICS ON PIPERAZINE BASIS
WO2010017466A3 (en) Phenobarbital salts; methods of making; and methods of use thereof
IN2012DN05142A (es)
GB0723504D0 (en) Treatment of eukaryotic cellular biomass
WO2010068920A3 (en) Diaminoquinazoline inhibitors of dihydrofolate reductase

Legal Events

Date Code Title Description
FA Abandonment or withdrawal